Institute

  • Print

The Institute for Biological and Medical Imaging (IBMI) of the HelmholtzZentrum München and the Technische Universität München focuses on the development and propagation of in-vivo imaging technology to the life sciences. These developments aim to applications spanning from basic research and drug discovery to pre-clinical imaging and clinical translation.

Biomedical imaging is increasingly becoming a keystone in bio-medical studies enabling a new paradigm of discovery by bridging the gap between research performed in-vitro and the clinical application. Fueled by key developments in in-vivo reporting on physiology and cellular and sub-cellular function and necessitated by corresponding applications to systems biology, -omics research, pre-clinical studies and their propagation towards molecular medicine, modern imaging approaches go beyond the anatomical or functional imaging of conventional radiological approaches and enable fundamentally new interrogations at the cellular, proteomic and genomic level. As such, modern biomedical imaging is enabling new insights into biological research and accelerates the propagation of new knowledge towards pre-clinical and clinical stages with the goal of improving healthcare and identifying cure faster than ever before.

Supported by the Chair for Biological Imaging at the Technical University of Munich, IBMI plays a central role into engineering necessary technology and work-platforms that enable in-vivo imaging from living micro-organisms to humans. With strategic locations at the Hemholtz Munich Center campus and the Technical University of Munich City Campus and Hospital, the Institute further connects basic research and clinical need and serves as an educational unit in imaging technology and application. To achieve these goals, IBMI integrates highly interdisciplinary skills and bridges mathematics, physics, engineering, chemistry, biology and medicine and invests in key focus areas, including the development of new imaging devices and multi-modality systems, advancing imaging and image reconstruction theories and methods, development of animal models for the interrogation of new technologies at the biological, pre-clinical and clinical level and advanced data and image processing methods and medical informatics. Key application areas include the development of new tools for the biomedical laboratory as well as the investigation of imaging methods for diagnostic and disease monitoring and treatment in key areas including cancer, inflammation, cardiovascular and neurodegenerative disease.